Role of tumor necrosis factor-α in graft-versus-host disease and graft-versus-leukemia responses

IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement.

M Sarmiento, Andrew L. Glasebrook, Frank W. Fitch · The Journal of Immunology · 1980 · 817 citations

Life Sciences, Biochemistry, Immunology +12

Cytokine dysregulation and acute graft-versus-host disease

JH Antin, JL Ferrara · Blood · 1992 · 608 citations · Full text

Medicine, Immunology, Pathology +14

Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors

Ferry Ossendorp, Erica Mengedé, Marcel Camps et al. · The Journal of Experimental Medicine · 1998 · 604 citations · Full text

Life Sciences, Immunology, Oncology +17

Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells

Rhodri Ceredig, John W. Lowenthal, Markus Nabholz et al. · Nature · 1985 · 600 citations

Life Sciences, Cell Biology, Immunology +14

Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.

P F Piguet, Georges E. Grau, Bernard Allet et al. · The Journal of Experimental Medicine · 1987 · 594 citations · Full text

Veterinary Medicine, Immunology, Pathology +17